Mani
7730.TTSE PRIMEPrecision Instruments
Filed as MANI,INC. (2022-07–2026-04)
Financials · Consolidated
| Fiscal year ended | 2025-08 | 2024-08 | 2023-08 | 2022-08 | 2021-08 | 2020-08 |
|---|---|---|---|---|---|---|
| Revenue | ¥30.0bn | ¥28.5bn | ¥24.5bn | ¥20.4bn | ¥17.2bn | ¥15.2bn |
| Operating income | ¥8.2bn | ¥8.4bn | ¥7.2bn | ¥6.2bn | ¥5.3bn | — |
| Ordinary income | ¥8.3bn | ¥8.5bn | ¥8.0bn | ¥7.5bn | ¥5.7bn | ¥4.4bn |
| Net income (owners) | ¥4.6bn | ¥6.3bn | ¥6.0bn | ¥5.3bn | ¥4.3bn | ¥3.3bn |
| Total assets | ¥58.0bn | ¥57.2bn | ¥55.0bn | ¥50.1bn | ¥42.7bn | ¥39.3bn |
| Net assets / equity | ¥53.6bn | ¥52.3bn | ¥49.8bn | ¥45.4bn | ¥39.2bn | ¥36.6bn |
| Operating cash flow | ¥7.0bn | ¥7.8bn | ¥8.0bn | ¥6.6bn | ¥6.4bn | ¥1.9bn |
| EPS (basic) | ¥47.14 | ¥63.82 | ¥60.46 | ¥53.75 | ¥43.6 | ¥33.83 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 14
| Period | Form | Figures |
|---|---|---|
| 2025-09-01 → 2026-02-28 | Half-year | 71 figures · EDINET |
| 2024-09-01 → 2025-08-31 | Annual | 201 figures · EDINET |
| 2024-09-01 → 2025-02-28 | Half-year | 71 figures · EDINET |
| 2023-09-01 → 2024-08-31 | AnnualAmended | 201 figures · EDINET |
| 2023-09-01 → 2024-08-31 | Annual | 201 figures · EDINET |
| 2023-09-01 → 2024-05-31 | Quarterly Q3 | 49 figures · EDINET |
| 2023-09-01 → 2024-02-29 | Quarterly Q2 | 73 figures · EDINET |
| 2023-09-01 → 2023-11-30 | Quarterly Q1 | 47 figures · EDINET |
| 2022-09-01 → 2023-08-31 | Annual | 201 figures · EDINET |
| 2022-09-01 → 2023-05-31 | Quarterly Q3 | 49 figures · EDINET |
| 2022-09-01 → 2023-02-28 | Quarterly Q2 | 73 figures · EDINET |
| 2022-09-01 → 2022-11-30 | Quarterly Q1 | 47 figures · EDINET |
| 2021-09-01 → 2022-08-31 | Annual | 201 figures · EDINET |
| 2021-09-01 → 2022-05-31 | Quarterly Q3 | 49 figures · EDINET |
25 more reports are still being processed.
Segments · FY ended 2025-08
| Segment | External sales | Profit |
|---|---|---|
| Dental Related Products | ¥9.5bn | ¥1.1bn |
| Eyeless Needle Related Products | ¥11.2bn | ¥4.0bn |
| Surgel Related Products | ¥9.3bn | ¥3.1bn |
| Adjustments & eliminations | — | — |
| Total | ¥30.0bn | ¥8.2bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.